Dipeptidyl Peptidase-4 Inhibitors and the Risk of Pancreatitis in Patients with Type 2 Diabetes Mellitus: A Population-Based Cohort Study.

Young Gun KimSeirhan KimSeung Jin HanDae Jung KimKwan-Woo Lee Hae Jin Kim

Published in: Journal of diabetes research (2018)

Our findings suggest that DPP-4i is less likely to cause drug-induced pancreatitis than SU. This finding was not evident in patients with CVD, but DPP-4i was not more likely to induce pancreatitis in these patients than SU was.

Keyphrases

drug induced
liver injury
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
patient reported outcomes
electronic health record